US Stock MarketDetailed Quotes
ACRX AcelRx Pharmaceuticals
Watchlist
0.7640
+0.0290+3.95% Close 12/01 16:00 ET
0.7550-0.0090-1.18%
Post 16:25 ET
0.7749High0.7378Low90.07KVolume
0.7700Open0.7350Pre Close68.25KTurnover0.75%Turnover RatioLossP/E (TTM)12.95MMarket Cap2.780052wk High0.13P/E (Static)16.95MShares0.425052wk Low0.71P/B9.19MFloat Cap272.8000Historical High--Dividend TTM12.03MShs Float0.4250Historical Low--Div YieldTTM5.04%Amplitude0.7570Avg Price1Lot Size
AcelRx Pharmaceuticals Key Stats
EPS
According to the latest financial report of AcelRx Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.08. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about AcelRx Pharmaceuticals's free cash flow? The latest report shows it as -2.96M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of AcelRx Pharmaceuticals shows that the company's current ratio is 4.04, indicating healthy liquidity.
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of AcelRx Pharmaceuticals, the quick ratio is 3.75, indicating that the company can meet its short-term debt obligations.
Quarterly
Loading...
ROE
Want to learn more about the financial health of AcelRx Pharmaceuticals? The latest ROE figure is -9.45%, indicating that the company has stable profitability.
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of AcelRx Pharmaceuticals, the total asset return on investment (ROA) is -6.62%.
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check AcelRx Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at -61.60K%.
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of AcelRx Pharmaceuticals, the net profit margin is -1.16K%, which is a good sign for its profitability.
Quarterly
Loading...